We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

STAT3 Inhibitor for Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00955812
Recruitment Status : Completed
First Posted : August 10, 2009
Last Update Posted : February 12, 2013
Otsuka Pharmaceutical Development & Commercialization, Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2012
  Study Completion Date : November 2012